Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. CRSP
CRSP logo

CRSP

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CRSP News

Gene Editing Sector Gains Momentum with Key Players CRISPR and Beam

5d agoFool

Analysis of Gene Editing Industry Prospects

5d agoNASDAQ.COM

2026 Investment Strategy: Focus on Quality Stocks

May 19 2026Fool

CRISPR Therapeutics Shows Promising Upside Potential

May 11 2026Fool

Vertex Pharmaceuticals: Investment Returns and Future Outlook

May 06 2026Fool

Vertex Pharmaceuticals' Future Outlook Appears Promising

May 06 2026NASDAQ.COM

CRISPR Therapeutics Q1 Earnings Report Exceeds Expectations

May 04 2026seekingalpha

Analysis of ARKK ETF's 52-Week Price Fluctuations

May 01 2026NASDAQ.COM

Healthcare Stocks: A Path to Wealth Growth

Apr 30 2026Fool

CRISPR Therapeutics: Potential Next Big Growth Area in Healthcare

Apr 30 2026Fool

CRISPR Therapeutics Shows Potential in Autoimmune Treatments

Apr 30 2026NASDAQ.COM

Pfizer's Dividend Growth Amid Market Transition

Apr 30 2026Fool

Analysis of Investment Value in High-Yield Stocks

Apr 30 2026NASDAQ.COM

Future Potential Stocks: CRISPR, Green Thumb, and Joby

Apr 29 2026Fool

CRISPR Therapeutics Secures Approval for First CRISPR-Based Medicine

Apr 21 2026Fool

CRISPR Therapeutics Improves Cash Position Amid Pipeline Expansion

Apr 13 2026Fool